Specifically, the article predicts that biologics may play a key role in the therapeutic options available and that identifying reliable biomarkers and developing standardised approaches could lead to individualised approaches to managing food allergy. 

The study explored the impact of COVID-19 on children with serious allergies.

The high prevalence of legume sensitisation and the frequent serious reactions reported in children with peanut allergy highlight that tolerated legume consumption should be explored for each legume in the case of peanut allergy.  

Allergy to cow’s milk is the most common food allergy affecting children. There is currently no accepted routine clinical therapy to cure milk allergy.

A recent trial by DBV Technologies has produced promising results for very young children with peanut allergies and their families. The trial assessed whether Viaskin Peanut – an immunotherapy skin patch – was safe, and if it worked for children

New research investigating the emotional impact of living with a peanut allergy has empathised the importance of exploring potential treatments. The study entitled Exploring Health-Related Quality of Life Burden in Peanut Allergy and the Potential Benefit of Oral Immunotherapy: Estimation

A study exploring trends in the use of specialised formula for cow’s milk allergy in young children has found a 2.8 fold increase since 2008 exceeding expected levels.

These recommendations aim to safely reduce overdiagnosis and better support breastfeeding women whose children have suspected a milk allergy. 

New research investigating the emotional impact of living with a peanut allergy has empathised the importance of exploring potential treatments. The study entitled Exploring Health-Related Quality of Life Burden in Peanut Allergy and the Potential Benefit of Oral Immunotherapy: Estimation of